immunogen inc (IMGN:NASDAQ GS)
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
2013 SEC Filings - immunogen inc (IMGN)
2012 SEC Filings - immunogen inc (IMGN)
2011 SEC Filings - immunogen inc (IMGN)
2010 SEC Filings - immunogen inc (IMGN)
| Recently Viewed | |||
| IMGN:US | $16.29 USD | +0.21 |  |
| Company | Last | Change |
| Bristol-Myers Squibb Co | $43.30 USD | +0.53 |
| Emergent Biosolutions Inc | $14.56 USD | +0.13 |
| Pfizer Inc | $28.96 USD | -0.29 |
| Roche Holding AG | SFr.247.00 CHF | +1.00 |
| Seattle Genetics Inc | $36.70 USD | +0.38 |
| View Industry Companies | ||
Industry Analysis
IMGN
Industry Average
| Valuation | IMGN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 39.1x |
|
| Price/Book | 9.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 33.3x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
